Importer of Controlled Substances; Notice of Registration, 799 [2011-11]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 4 / Thursday, January 6, 2011 / Notices
Issued: December 30, 2010.
Marilyn R. Abbott,
Secretary to the Commission.
Drug
Sufentanil (9740) ..........................
[FR Doc. 2010–33355 Filed 1–5–11; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated June 17, 2010, and
published in the Federal Register on
June 28, 2010, 75 FR 36680, United
States Pharmacopeial Convention,
12601 Twinbrook Parkway, Rockville,
Maryland 20852, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Schedule
Cathinone (1235) ..........................
Methaqualone (2565) ...................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Methyl-2,5dimethoxyamphetamine (7395).
3,4-Methylenedioxyamphetamine
(7400).
Codeine-n-oxide (9053) ................
Heroin (9200) ...............................
Amphetamine (1100) ....................
Drug
erowe on DSK5CLS3C1PROD with NOTICES
I
The company plans to import
reference standards for sale to
researchers and analytical labs.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
United States Pharmacopeial
Convention to import the basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated United States
Pharmacopeial Convention to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: December 23, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
I
I
II
Dated: December 23, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–11 Filed 1–5–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
[FR Doc. 2011–12 Filed 1–5–11; 8:45 am]
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
BILLING CODE 4410–09–P
Employee Benefits Security
Administration
DEPARTMENT OF JUSTICE
Publication of Year 2010 Form M–1
With Electronic Filing Option, Notice
Drug Enforcement Administration
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
By Notice dated October 15, 2010, and
published in the Federal Register on
October 26, 2010, 75 FR 65660,
Noramco Inc., 1440 Olympic Drive,
Athens, Georgia 30601, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Schedule
Thebaine (9333) .........................
Tapentadol (9780) ......................
II
II
II
II
II
The company plans to import
Thebaine (9333) analytical reference
standards for distribution to its
customers. The company plans to
Jkt 223001
Employee Benefits Security
Administration, Department of Labor.
ACTION: Notice on the Availability of the
Year 2010 Form M–1 with Electronic
Filing Option.
AGENCY:
Importer of Controlled Substances;
Notice of Registration
Schedule
Drug
15:07 Jan 05, 2011
I
I
I
I
I
I
II
import an intermediate form of
Tapentadol (9780) to bulk manufacture
Tapentadol for distribution to its
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Noramco Inc. to import the basic classes
of controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated Noramco Inc. to ensure that
the company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Schedule
Methamphetamine (1105) ............
Phenmetrazine (1631) ..................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Phencyclidine (7471) ....................
Alphaprodine (9010) .....................
Anileridine (9020) .........................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) ......................
Meperidine (9230) ........................
Methadone (9250) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
VerDate Mar<15>2010
Schedule
799
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
II
II
This document announces the
availability of the Year 2010 Form M–
1, Annual Report for Multiple Employer
Welfare Arrangements and Certain
Entities Claiming Exception. It is
generally identical to the 2009 Form M–
1, except that a few changes were made
to update the Part 7 compliance
questions to reflect the current
provisions of Part 7 that were effective
in 2010. The Form M–1 may again be
filed electronically over the Internet.
FOR FURTHER INFORMATION CONTACT: For
inquiries regarding the Form M–1 filing
requirement, contact Amy J. Turner or
Beth L. Baum, Office of Health Plan
Standards and Compliance Assistance,
SUMMARY:
E:\FR\FM\06JAN1.SGM
06JAN1
]]>Agencies
[Federal Register Volume 76, Number 4 (Thursday, January 6, 2011)]
[Notices]
[Page 799]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-11]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated October 15, 2010, and published in the Federal
Register on October 26, 2010, 75 FR 65660, Noramco Inc., 1440 Olympic
Drive, Athens, Georgia 30601, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Thebaine (9333)............................ II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import Thebaine (9333) analytical reference
standards for distribution to its customers. The company plans to
import an intermediate form of Tapentadol (9780) to bulk manufacture
Tapentadol for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Noramco Inc. to import the basic classes of controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. DEA has investigated Noramco Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and
958(a), and in accordance with 21 CFR 1301.34, the above named company
is granted registration as an importer of the basic classes of
controlled substances listed.
Dated: December 23, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-11 Filed 1-5-11; 8:45 am]
BILLING CODE 4410-09-P
